(Q37979165)

English

Eribulin mesylate for the treatment of patients with refractory metastatic breast cancer: use of a "physician's choice" control arm in a randomized approval trial

scientific article published on 26 January 2012

Statements

Eribulin mesylate for the treatment of patients with refractory metastatic breast cancer: use of a "physician's choice" control arm in a randomized approval trial (English)
Rajeshwari Sridhara
Richard Lostritto
Joseph E Gootenberg

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit